Treatment Approach for Splenic Injuries Based on AAST Grading
Hemodynamically stable patients with any grade of splenic injury should receive non-operative management (NOM) as the standard of care, with angiography/angioembolization (AG/AE) reserved for AAST Grade IV-V injuries or any grade with contrast blush on CT scan. 1
Initial Management Algorithm
Hemodynamic Status Assessment (Primary Determinant)
Hemodynamically unstable patients require immediate operative management regardless of AAST grade. 2
- Unstable patients unresponsive to resuscitation with any grade splenic injury need splenectomy 2
- Hemodynamic stability is more critical than anatomic injury grade in determining treatment strategy 3
Hemodynamically stable patients proceed to CT-based grading and selective intervention. 1, 3
Grade-Specific Treatment Protocols
AAST Grade I-II (Low-Grade Injuries)
- Observation with serial abdominal examinations and hematocrit checks every 6 hours for the first 24-72 hours 1
- NOM success rate exceeds 95% in these patients 1
- AG/AE is not routinely indicated even if contrast blush is present, as only 4% show active bleeding vascular injuries 1
- No routine post-discharge CT imaging required 1
- Activity restriction for 2 weeks with return to full activity at 6 weeks 1
AAST Grade III (Moderate Injuries)
- NOM with close observation is appropriate for patients without contrast blush 1
- Prophylactic AG/AE should NOT be performed routinely in Grade III injuries without vascular abnormalities 1
- NOM failure occurs in only 3% of Grade III lesions without blush 1
- The AG/AE-related morbidity of 47% versus 10% for NOM alone does not justify routine embolization 1
- Consider repeat CT at 36-72 hours if hematocrit is decreasing 1
- Activity restriction for 2.5-3 months before return to normal activity 1
AAST Grade IV-V (High-Grade Injuries)
These patients require AG/AE if hemodynamically stable, as NOM failure without embolization is unacceptably high. 1
- NOM failure rates: 43.7% for Grade IV and 83.1% for Grade V without AG/AE versus 17.3% and 25.0% respectively with AG/AE 1
- Success rate of AG/AE ranges from 73-100% 1
- Coils should be preferred over temporary agents for embolization 1
- Proximal or combined proximal/distal embolization should be used for severe lesions 1
- Level I trauma centers with AG/AE rates >10% have significantly higher spleen salvage rates 1
- Activity restriction for 4-6 months 1
CT Findings That Mandate Intervention
Contrast Blush/Active Bleeding
Any patient with contrast blush on CT requires AG/AE regardless of AAST grade. 1
- NOM failure with contrast blush treated without AG/AE ranges from 67-82% 1
- Intraperitoneal splenic blush has significantly higher risk of hemodynamic deterioration than intraparenchymal bleeding (p < 0.001) 1
- Angiographic procedure without embolization increases twofold the risk of re-bleeding and NOM failure 1
Pseudoaneurysm (PSA) or Arteriovenous Fistula
- These vascular injuries require AG/AE as they show higher NOM failure rates 1
- PSA accuracy for predicting need for AG/AE is 83% 1
Operative Management Indications
Proceed directly to splenectomy for: 2
- Hemodynamic instability despite resuscitation
- Failed NOM with ongoing bleeding or deterioration
- Total splenic avulsion (Grade V with complete devascularization)
- Grade IV injuries in centers without AG/AE capability
- Unipolar apical laceration with uncontrolled active bleeding
Critical Pitfalls and Caveats
Timing of AG/AE
- Earlier AG/AE correlates with fewer splenectomies - delay increases failure risk 1
- Multi-institutional data shows AG/AE is an independent predictor of spleen salvage and mortality reduction 1
False-Negative Angiography
- 2.3-47% of CT-detected contrast blush cannot be confirmed at subsequent angiography 1
- However, this should not deter proceeding to angiography, as the presence of blush remains highly predictive
Grade III Controversy
- Do not routinely embolize Grade III injuries without vascular abnormalities 1
- Widening AG/AE criteria from Grade IV-V to Grade III-V only marginally decreases NOM failure but significantly increases morbidity 1
- No outcome deterioration in mortality or complications when Grade III is excluded from routine AG/AE protocols 1